Literature DB >> 8560735

Association with HeLa cells by Rhodococcus equi with and without the virulence plasmid.

A de la Peña-Moctezuma1, J F Prescott.   

Abstract

HeLa cell association was examined in eight Rhodococcus equi isolates containing 80-85 kb plasmids and their plasmid negative derivatives, and in two other plasmid negative R. equi strains. Seven of the eight plasmid positive strains possessed an 85 kb plasmid and produced the virulence-associated protein (VapA) detected by monoclonal antibody staining in immunoblots; one of the eight had an 80 kb plasmid but did not produce VapA. Curing of the plasmids by repetitive subcultures at 42 degrees C in broth was confirmed by colony and DNA dot blot hybridization with a 7.5 kb BamHI-HindIII plasmid fragment probe, by attempted isolation of plasmid DNA, and by demonstration of lack of VapA. Most strains associated well with HeLa cells and no relationship was found with plasmid status and possession of VapA. Association with HeLa cells was significantly greater for strains with a dry colony type than for those with a mucoid colony, a result which correlated with hydrophobicity of the colonies. HeLa cell association does not correlate with the presence of the virulence plasmid in R. equi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8560735     DOI: 10.1016/0378-1135(95)00034-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

1.  Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi.

Authors:  S Giguère; J F Prescott
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Isocitrate lyase activity is required for virulence of the intracellular pathogen Rhodococcus equi.

Authors:  Daniel M Wall; Pamela S Duffy; Chris Dupont; John F Prescott; Wim G Meijer
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi.

Authors:  S Giguère; B N Wilkie; J F Prescott
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Structural definition of trehalose 6-monomycolates and trehalose 6,6'-dimycolates from the pathogen Rhodococcus equi by multiple-stage linear ion-trap mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Jens Wohlmann; John Turk; Albert Haas
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-05       Impact factor: 3.109

5.  Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi.

Authors:  S Giguère; M K Hondalus; J A Yager; P Darrah; D M Mosser; J F Prescott
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  Characterization of mycolic acids from the pathogen Rhodococcus equi by tandem mass spectrometry with electrospray ionization.

Authors:  Fong-Fu Hsu; Kristina Soehl; John Turk; Albert Haas
Journal:  Anal Biochem       Date:  2010-10-12       Impact factor: 3.365

7.  The intracellular pathogen Rhodococcus equi produces a catecholate siderophore required for saprophytic growth.

Authors:  Raúl Miranda-CasoLuengo; John F Prescott; José A Vázquez-Boland; Wim G Meijer
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

8.  IcgA is a virulence factor of Rhodococcus equi that modulates intracellular growth.

Authors:  Xiaoguang Wang; Garry B Coulson; Aleksandra A Miranda-Casoluengo; Raúl Miranda-Casoluengo; Mary K Hondalus; Wim G Meijer
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

9.  The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development.

Authors:  R van der Geize; A W F Grommen; G I Hessels; A A C Jacobs; L Dijkhuizen
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

10.  A real-time impedance based method to assess Rhodococcus equi virulence.

Authors:  Aleksandra A Miranda-CasoLuengo; Raúl Miranda-CasoLuengo; Nora T Lieggi; Haixia Luo; Jeremy C Simpson; Wim G Meijer
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.